NASDAQ:SRTS Sensus Healthcare Q3 2026 Earnings Date & Estimates $2.75 -0.01 (-0.36%) Closing price 11/2/2026 04:00 PM EasternExtended Trading$2.76 +0.02 (+0.55%) As of 11/2/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Sensus Healthcare is estimated to report Q3 2026 earnings on Thursday, November 12, 2026, after market closes. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 12, 2026TimeAfter Market ClosesConference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Sensus Healthcare in Q3 2026Sensus Healthcare is expected to post earnings of -$0.0550 per share on revenue of $6.61 million. In the same quarter a year earlier Sensus Healthcare reported -$0.06 per share on revenue of $6.88 million. Sensus Healthcare last reported on August 13, 2026, posting -$0.53 per share and missing the -$0.1250 consensus estimate. Sensus Healthcare has beaten the consensus EPS estimate in 2 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.0550Expected Revenue$6.61 millionPrior-Year EPS-$0.06Prior-Year Revenue$6.88 millionExpected Revenue Growth-3.9%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.53 (Missed by -$0.4050)Last Quarter Revenue$2.29 millionEPS Beat Rate2 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Sensus Healthcare Q3 2026 Earnings FAQ When does Sensus Healthcare report Q3 2026 earnings? Sensus Healthcare (NASDAQ:SRTS) is estimated to report Q3 2026 earnings on Thursday, November 12, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Sensus Healthcare's Q3 2026 earnings call? Sensus Healthcare's Q3 2026 earnings conference call is scheduled for Thursday, November 12, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Sensus Healthcare? Analysts expect Sensus Healthcare to post earnings of -$0.0550 per share for Q3 2026. How much revenue is Sensus Healthcare expected to report? The consensus revenue estimate for Sensus Healthcare is $6.61 million for Q3 2026. Sensus Healthcare Earnings HeadlinesSensus Healthcare IncAugust 31, 2026 | money.usnews.comSensus (SRTS) Q2 2026 Earnings Call TranscriptAugust 21, 2026 | finance.yahoo.comA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. | Porter & Company (Ad)Sensus outlines shift to $250,000 average selling price as it targets a stronger second halfAugust 14, 2026 | seekingalpha.comSensus Healthcare, Inc. (SRTS) Q2 2026 Earnings Call TranscriptAugust 13, 2026 | seekingalpha.comSensus Healthcare Reports Second Quarter 2026 Financial Results and Business HighlightsAugust 13, 2026 | businesswire.comSee More Sensus Healthcare Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Sensus Healthcare? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sensus Healthcare and other key companies, straight to your email. Email Address About Sensus HealthcareSensus Healthcare (NASDAQ:SRTS) is a medical device company focused on non-invasive treatment technologies for dermatologic and oncologic conditions. The company develops and commercializes superficial radiotherapy systems designed to deliver low-energy X-rays to targeted areas of the skin. Its principal products include the SRT-100 and SRT-100 Vision systems, which are used by physicians to treat non-melanoma skin cancers, including basal cell and squamous cell carcinomas, as well as keloids. The systems are intended to provide an alternative to certain surgical procedures and are used in dermatology, radiation oncology and other clinical settings. Founded in 2010, Sensus Healthcare is headquartered in Boca Raton, Florida. The company markets its products primarily through a combination of direct sales and distribution relationships in the United States and selected international markets. Joseph C. Sardano has served as the company’s chairman and chief executive officer.View Sensus Healthcare ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles AbbVie's Humira Era Is Fading, But Its New Growth Engines Face Another TestAlphabet’s $400 Billion Sell-Off Could Be the Best AI Buying Window Left in 2026Exxon's Refining Profits Soared—Did Chevron Get the Same Windfall?LyondellBasell's Dividend Looks Safer, But a New Risk Could Change ThatUranium Prices Are Near Historic Highs—So Why Hasn’t Cameco Followed?Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?Silicon Shock: Intel's 25% Valuation Reset Upcoming Earnings Booking (11/3/2026)Ferrari (11/3/2026)Marathon Petroleum (11/3/2026)Mplx (11/3/2026)Suncor Energy (11/3/2026)Apollo Global Management (11/3/2026)Itau Unibanco (11/3/2026)Amgen (11/3/2026)Pfizer (11/3/2026)Eaton (11/3/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
